Announcements Trials

Browse Landscape

Status

Completed 22 Unknown 10 Recruiting 6 Terminated 5 Suspended 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 32 Neoplasms 28 Colorectal Neoplasms 19 Prostatic Neoplasms 16 Lung Neoplasms 13 Leukemia, Myeloid, Acute 12 Glioblastoma 12 Stomach Neoplasms 10 Head and Neck Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Pancreatic Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Melanoma 8 Glioma 8 Brain Neoplasms 8 Rectal Neoplasms 7 Carcinoma, Hepatocellular 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Hematologic Neoplasms 6 Uterine Cervical Neoplasms 5 Polycystic Ovary Syndrome 5 Myelodysplastic Syndromes 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Carcinoma, Renal Cell 5 Triple Negative Breast Neoplasms 4 Lymphoma, B-Cell 4 Lymphoma 4 Depression 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × OTHER × Hyperandrogenism × Clear all

NCT02611128 2023-11-02

DENND1A

University of Virginia

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡